Research Objective The candidate is a fixed dose binary small molecule drug combination, consisting of two agents that act synergistically on a multipotent stem cell population in the CNS to…
Multiple Sclerosis (MS) is a disease of the central nervous system (CNS) caused by inflammation and loss of cells that produce myelin, which normally insulates and protects nerve cells. MS…
Multiple sclerosis (MS) is an autoimmune disease in which the myelin sheath that insulates neurons is destroyed, resulting in loss of proper neuronal function. Existing treatments for MS are based…
Strokes that affect the nerves cells, i.e., “gray matter”, consistently receive the most attention. However, the kind of strokes that affecting the “wiring” of the brain, i.e., “white matter”, cause…
Multiple sclerosis (MS) is the most common neurologic disease affecting young adults under the age of 40 with the majority of MS patients diagnosed in the second or third decade…
Dr. Tom Lane of the University of Utah (formerly a CIRM grantee at UC-Irvine) describes his lab's experimental results that show a dramatic reversal in the debilitating effects of a…
For more information about CIRM-funded MS research, visit our fact sheet. In her twenties, the left side of Nan Luke's body went numb from the bottom of her foot up…
Get the latest CIRM news, information on upcoming meetings, and funding opportunities delivered to your inbox.
